Protein-protein interactions (PPI) play a key role in life processes. Studies have shown that abnormal PPIs are associated with various diseases, including cancer, infectious diseases and neurodegenerative diseases. Therefore, targeting PPIs is a direction for the treatment of diseases and a useful strategy for the development of new drugs. Nowadays, classical small molecule drug discovery approaches have focused on protein-ligand interactions, such as enzymes, ion channels or receptors, because these proteins often contain well-defined ligand binding sites that small molecules can interact with. The biological activity of any given molecule essentially depends on the 3D shape of its PPI library. Moreover, the molecular shape diversity of a small molecule library is the most fundamental indicator of overall functional diversity.
With this in mind, BOC Sciences has designed a proprietary eccentric PPI library to provide a variety of structurally diverse molecular compounds.
Figure 1. In DOS, libraries of structurally diverse compounds are derived from common intermediates. (Tzakos, A. G.; et al. 2011)
When designing our eccentric PPI library, we take the following principles into consideration: diversity, 3D-shape, escape from flatland, drug-likeness, natural product likeness and targeted diversity
At BOC Sciences, there are six principle components of structural diversity that have been consistently identified in the literature:
Figure 2. Several three dimensional structures of protein-protein interactions have been targeted by DOS. (Tzakos, A. G.; et al. 2011)
BOC Sciences provides professional, rapid and high-quality services of Eccentric PPI Library design at competitive prices for global customers. Personalized and customized services of Eccentric PPI Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.